|
| 38073596 | Incidence and outcomes of hospital-associated respiratory virus infections by viral species. | Infect Control Hosp Epidemiol | 2024 |
| 36327388 | Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022. | Clin Infect Dis | 2023 |
| 38026207 | Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2. | iScience | 2023 |
| 37662226 | SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis. | medRxiv | 2023 |
| 37796753 | Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged â¿¥60 Years - IVY Network, 20 U.S. States, February 2022-May 2023. | MMWR Morb Mortal Wkly Rep | 2023 |
| 37882522 | Deep mutational scanning reveals the functional constraints and evolutionary potential of the influenza A virus PB1 protein. | J Virol | 2023 |
| 37975674 | Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection. | J Virol | 2023 |
| 35580849 | Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States. | Clin Infect Dis | 2023 |
| 37325086 | Mutual information networks reveal evolutionary relationships within the influenza A virus polymerase. | Virus Evol | 2023 |
| 37089775 | Successful Treatment of Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Immunodeficiency With Extended Nirmatrelvir/Ritonavir: Case Series. | Open Forum Infect Dis | 2023 |
| 37255285 | Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022. | Clin Infect Dis | 2023 |
| 37246148 | Risk factors for infection with influenza A(H3N2) virus on a US university campus, October-November 2021. | Influenza Other Respir Viruses | 2023 |
| 37104244 | Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023. | MMWR Morb Mortal Wkly Rep | 2023 |
| 37301704 | Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022. | Vaccine | 2023 |
| 37127782 | A rapid and flexible microneutralization assay for serological assessment of influenza viruses. | Influenza Other Respir Viruses | 2023 |
| 36883903 | Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants. | J Infect Dis | 2023 |
| 36694363 | Prevalence and Clinical Outcomes of Respiratory Syncytial Virus vs Influenza in Adults Hospitalized With Acute Respiratory Illness From a Prospective Multicenter Study. | Clin Infect Dis | 2023 |
| 36650162 | Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants. | Nat Commun | 2023 |
| 36580913 | Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. | Cell | 2023 |
| 36608647 | Polio eradication: Addressing the hurdles on the last mile. | Cell | 2023 |
| 36909579 | Type I interferon signaling induces a delayed antiproliferative response in Calu-3 cells during SARS-CoV-2 infection. | bioRxiv | 2023 |
| 36909298 | K-medoids clustering of hospital admission characteristics to classify severity of influenza virus infection. | Influenza Other Respir Viruses | 2023 |
| 36824962 | Mutual information networks reveal evolutionary relationships within the influenza A virus polymerase. | bioRxiv | 2023 |
| 36701144 | Household Transmission of Influenza A Viruses in 2021-2022. | JAMA | 2023 |
| 36700653 | Virology under the Microscope-a Call for Rational Discourse. | mSphere | 2023 |
| 36700642 | Virology under the Microscope-a Call for Rational Discourse. | mBio | 2023 |
| 36700640 | Virology under the Microscope-a Call for Rational Discourse. | J Virol | 2023 |
| 36861093 | Investigating Epidemiologic and Molecular Links Between Patients With Community- and Hospital-Acquired Influenza A: 2017-2018 and 2019-2020, Michigan. | Open Forum Infect Dis | 2023 |
| 35324878 | Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35675695 | Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States. | Clin Infect Dis | 2022 |
| 35798681 | The variant-specific burden of SARS-CoV-2 in Michigan: March 2020 through November 2021. | J Med Virol | 2022 |
| 35818721 | Ascertainment of vaccination status by self-report versus source documentation: Impact on measuring COVID-19 vaccine effectiveness. | Influenza Other Respir Viruses | 2022 |
| 35385875 | mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients. | J Infect Dis | 2022 |
| 36695662 | Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022. | Open Forum Infect Dis | 2022 |
| 36580424 | Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged â¿¥65 Years - IVY Network, 18 States, September 8-November 30, 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36424890 | SARS-CoV-2 Vaccine Strain Selection: Guidance From Influenza. | J Infect Dis | 2022 |
| 36264830 | Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36263068 | Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants. | bioRxiv | 2022 |
| 36220174 | Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study. | BMJ | 2022 |
| 36377913 | SARS-CoV-2 Genomic Diversity in Households Highlights the Challenges of Sequence-Based Transmission Inference. | mSphere | 2022 |
| 36374708 | Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States. | Vaccine | 2022 |
| 33487199 | Coronavirus disease 2019 (COVID-19) research agenda for healthcare epidemiology. | Infect Control Hosp Epidemiol | 2022 |
| 35085218 | Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021. | MMWR Morb Mortal Wkly Rep | 2022 |
| 34932114 | Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021. | J Infect Dis | 2022 |
| 35264324 | Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. | BMJ | 2022 |
| 32877923 | Severe Acute Respiratory Syndrome Coronavirus 2 Surveillance in Decedents in a Large, Urban Medical Examiner's Office. | Clin Infect Dis | 2021 |
| 33600489 | Pre-existing heterosubtypic immunity provides a barrier to airborne transmission of influenza viruses. | PLoS Pathog | 2021 |
| 33826681 | Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts. | PLoS Pathog | 2021 |
| 33822773 | SARS-CoV-2 vaccines: a triumph of science and collaboration. | JCI Insight | 2021 |
| 33565705 | Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing. | Am J Transplant | 2021 |